Nanosonics Limited
ASX: NAN
Nanosonics Limited develops and commercialises infection prevention and decontamination technologies for the healthcare sector. The company operates across North America, Europe & Middle East, and Asia Pacific. Its key offerings include trophon EPR, trophon technology, and trophon2 systems. Founded by Maurie Stang in 2000, Nanosonics is headquartered in Sydne
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
PG Weekly Pick
A$100.00
Already a subscriber?
Sign in to read this report.
Required subscription
PG Weekly Pick
Receive one high-conviction ASX stock idea every week, backed by detailed research, risk analysis, and a clear investment thesis designed to help you focus on quality opportunities.
- ✓ One Premium ASX Stock Pick Weekly
- ✓ Delivered Every Friday
- ✓ Buy / Hold / Sell Guidance & Risk Rating
- ✓ Full Historical Pick Access
A$100.00/ 1 months
Risk:High
Subscribe Now →